The proposed bill H.202 aims to enhance transparency in prescription drug costs and spending by implementing several key provisions. It prohibits pharmacy benefit managers from charging covered individuals more than the National Average Drug Acquisition Cost plus a professional dispensing fee for prescription drugs. Additionally, pharmacies will be required to post notices informing customers that they can request information about their price options, including the cost-sharing amount under their health plan and any applicable discounts. Hospitals participating in the federal 340B drug pricing program will also be mandated to report their participation annually to the Green Mountain Care Board, detailing their acquisition costs and how savings from the program benefit their communities.

Furthermore, health insurers will need to provide annual reports to covered individuals, outlining the total amount spent on prescription drugs on their behalf, net of rebates and discounts. Covered entities in the 340B program must notify patients if their prescribed drugs were purchased through this program and direct them to the Green Mountain Care Board's website for further information. The bill is set to take effect on July 1, 2025, with the first report from hospitals due by July 1, 2026.

Statutes affected:
As Introduced: 18-3612